Back to Programme

Scotland at a Crossroads: Securing the Future through Health Research and Innovation

12:40 – 13:20

ABPI logo

   ABPI Supported Session

 

Scotland is recognised for its research excellence, integrated healthcare system, world-class universities and strong life sciences sector. As international competition for investment, clinical trials and talent grows, stronger collaboration is essential.
This session brings together leaders from government, the NHS, academia and industry to discuss how Scotland can turn research strengths into better patient outcomes and economic growth. The panel will explore increasing commercial clinical research, making better use of health data and accelerating adoption of innovative medicines and technologies. It will also address workforce and service challenges, asking what Scotland must do now to remain globally competitive.

Speakers

Professor Dame Anna Dominiczak

Professor Dame Anna Dominiczak

Chief Scientist (Health), Scottish Government

Professor Dame Anna Dominiczak was appointed Chief Scientist (Health) for Scotland in July 2022.
Professor Alison Strath

Professor Alison Strath

Chief Pharmaceutical Officer, Scottish Government

Professor Alison Strath was appointed Chief Pharmaceutical Officer for Scotland in 2021.
Professor Jann Gardner

Professor Jann Gardner

Chief Executive, NHS Greater Glasgow and Clyde

Professor Jann Gardner is Chief Executive of NHS Greater Glasgow and Clyde, Scotland's largest NHS Board, leading one of the UK's most complex healthcare systems.
Dr Richard Torbett MBE

Dr Richard Torbett MBE

Chief Executive, Association of the British Pharmaceutical Industry (ABPI)

Dr Richard Torbett MBE has been Chief Executive of the Association of the British Pharmaceutical Industry (ABPI) since January 2020.